| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $36.3M | +4.1% |
| Cost of Revenue | $24.1M | -0.6% |
| Gross Profit | $12.3M | +14.9% |
| R&D Expense | $604K | -35.3% |
| SG&A Expense | $18.5M | +12.1% |
| Operating Income | -$6.2M | -7.1% |
| Pre-tax Income | -$6.0M | -10.9% |
| Income Tax | $22K | +109.2% |
| Net Income | -$6.0M | -16.4% |
| EPS (Basic) | -$1.44 | +80.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $3.5M | -10.6% |
| Inventory | $13.5M | +19.5% |
| Current Assets | $26.9M | +3.4% |
| Total Assets | $30.1M | -1.6% |
| Current Liabilities | $6.4M | +2.0% |
| Total Liabilities | $7.0M | -0.3% |
| Stockholders' Equity | $23.0M | -2.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +57.5% |
| Capital Expenditures | $174K | -89.5% |
| Investing Cash Flow | -$836K | +64.0% |
| Financing Cash Flow | $4.7M | -48.9% |
| Free Cash Flow | -$5.5M | +61.2% |